Search Results1-12 of  12

  • SUMIYOSHI TOMIKI ID: 9000001742010

    Department of Neuropsychiatry, Faculty of Medicine, Toyama Medical and Pharmaceutical University (2000 from CiNii)

    Articles in CiNii:1

    • Changes in limbic dopamine metabolism following quinolinic acid lesions of the left entorhinal cortex in rats (2000)
  • SUMIYOSHI TOMIKI ID: 9000001919673

    Department of Neuropsychiatry, School of Medicine, Toyama Medical and Pharmaceutical University (2002 from CiNii)

    Articles in CiNii:1

    • Minnesota Multiphasic Personality Inventory profile characteristics of schizotypal personality disorder (2002)
  • SUMIYOSHI Tomiki ID: 1000080286062

    Articles in CiNii:19

    • Effects of intracerebroventricular administration of NMDA-R1 antisense oligodeoxynucleotide on midbrain dopamine neuronal activity (1999)
    • 統合失調症における脳形態の変化とストレス脆弱性 (2007)
    • サイコーシス早期段階における生物学的所見 (2010)
  • SUMIYOSHI Tomiki ID: 9000001686808

    Department of Psychiatry, Division of Psychopharmacology, Vanderbilt University School of Medicine (2005 from CiNii)

    Articles in CiNii:1

    • Prediction of the ability of clozapine to treat negative symptoms from plasma glycine and serine levels in schizophrenia (2005)
  • SUMIYOSHI Tomiki ID: 9000019194534

    Department of Neuropsychiatxy, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences (2012 from CiNii)

    Articles in CiNii:2

    • Essentials of neurocognitive assessment in clinical research (2012)
    • Pharmacotherapy for early intervention and prevention of schizophrenia (2011)
  • SUMIYOSHI Tomiki ID: 9000399359215

    Toyama University (2010 from CiNii)

    Articles in CiNii:1

    • Working memory in schizophrenia::performance on the letter number sequence task (2010)
  • Sumiyoshi Tomiki ID: 9000006641474

    Articles in CiNii:1

    • In Vivo Dopamine-D1, D2 and Serotonin-5-HT2 Receptor Binding Study of Typical and Atypical Antipsychotic Drugs (1993)
  • Sumiyoshi Tomiki ID: 9000345376373

    Department of Clinical Research Promotion, National Center of Neurology and Psychiatry (2014 from CiNii)

    Articles in CiNii:1

    • Do atypical antipsychotic drugs enhance cognition in schizophrenia? -Preclinical and clinical evidence (2014)
  • Sumiyoshi Tomiki ID: 9000345376597

    Department of Clinical Research Promotion, National Center Hospital, National Center of Neurology and Psychiatry (2014 from CiNii)

    Articles in CiNii:1

    • Early identification of markers of variations in trajectories of outcome in psychotic disorders (2014)
  • Sumiyoshi Tomiki ID: 9000345376607

    National Center Hospital, National Center of Neurology and Psychiatry (2014 from CiNii)

    Articles in CiNii:1

    • Neurocognitive impairment and visualizing techniques in major psychoses : An overview (2014)
  • Sumiyoshi Tomiki ID: 9000345376778

    Department of Clinical Research Promotion, National Center of Neurology and Psychiatry (2015 from CiNii)

    Articles in CiNii:1

    • T-817MA, a novel neurotrophic agent, as a new pharmacotherapy of schizophrenia (2015)
  • Sumiyoshi Tomiki ID: 9000402945110

    Department of Preventive Intervention for Psychiatric Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry (2019 from CiNii)

    Articles in CiNii:1

    • Application of event-related potentials (ERPs) for pharmacotherapy in schizophrenia patients (2019)
Page Top